At UCLA, comprehensive clinical care for eye cancer is provided primarily through the Ophthalmic Oncology Center, which is facilitated by the Jules Stein Eye Institute.
Consistently ranked as the best eye care center in the Western United States by U.S. News & World Report and Ophthalmology Times, the Jules Stein Eye Institute offers a full range of services for patients of all ages. Services are provided in private consultation with some of the most skilled and highly qualified eye and vision care specialists in the world.
The Ophthalmic Oncology Center serves adults and children with tumors of the eye, eyelid and orbit. Patients with confirmed ocular melanoma are offered options for care that are often not available in the community. Options involve enucleation of the eye, radioactive plaque therapy, transpupillary thermotherapy (TTT) and laser surgery.
Treatment is closely coordinated with UCLA internists, oncologists and radiation oncologists. Patients with simulating diseases, such as common nevi, are closely followed by Center physicians. Full-time faculty members provide consultation and treatment, including surgical services. They have extensive, advanced training in ophthalmic subspecialties, which enables them to offer emerging therapies.
Clinical trials are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective. Each study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies.
If you are interested in finding out more about these studies, visit our Enroll in a Clinical Trial section for general information and a listing of currently open clinical trials.
Learn more about eye cancer services at UCLA by visiting the following related website: